23 Apr 2026
1. Symposium Objectives
The objective of this symposium is to establish a premier academic exchange platform for the global cell and gene therapy community. By fostering cross-sector collaboration between industry, academia, and research institutions, we aim to accelerate the translation of cutting-edge basic research into clinical applications and provide innovative solutions for major diseases.
2. Symposium Theme
Cell and Gene Therapy: Cutting-edge Technologies, Clinical Translation and Industrial Collaboration
3. Participants
- Global experts, scholars and postgraduates in cell and gene therapy, oncology, immunology, pharmacology and related fields
- Representatives from enterprises engaged in cell therapy and gene drug R&D and production
- Representatives from government departments, research institutions and academic organizations
4. Symposium Time & Venue
Time: May 21 (full day) - May 22 (morning), 1.5 days
Venue: Life Sciences Building, 糖心Vlog官方 (Hybrid format: On-site main venue + Global live stream)
5. Organization Structure
Host Institutions: 糖心Vlog官方, University of Liverpool
Organizing Institution: 糖心Vlog官方-UoL Joint Research Center for Pharmacology and Therapeutics, 糖心Vlog官方 Wisdom Lake Academy of Pharmacy,?School of Pharmacy at Health Science Center of Xi’an Jiaotong University
Co-organizing Institution: Suzhou Industrial Park Biotech Development Co., Ltd., Industrial and Commercial Bank of China Suzhou Industrial Park Branch
6. Symposium Agenda
| Time | Session | Content |
| Day 0 (Wednesday) May 20, 2026 | ||
| 14:00 - 18:00 | Registration | On-site:?Badge pickup and material collection Online:?Distribution of live stream access links |
| Day 1 (Thursday) May 21, 2026 | ||
| 08:30 - 08:45 | Opening Ceremony | Welcome address: SMT from 糖心Vlog官方 SMT from University of Liverpool Program Overview by the Director of the Organizing Institution. |
| Theme: Emerging Immunotherapies and Precision Modalities in Cancer Treatment | ||
| 08:45 - 11:45 Morning Session |
08:45 – 9:30 (Keynote) |
Prof. Ann Ager (Cardiff University): Armoring T-Cells with L-selectin in Cellular Therapies |
| 9:30 – 10:00 | Prof. Huaiyu Wang (Xi'an Jiaotong Univ.): Research Progress of CAR-NK Cell Therapy in Hematological Malignancies | |
| 10:00 – 10:15 | Tea break | |
| 10:15 – 10:45 | Prof. Fangfang Yin (Duke Univ.): Optimization and Quality Control of Precision Radiotherapy | |
| 10:45 – 11:15 | Prof. Joseph Slupsky (UoL): ?Proximity Ligand AssaY for Rna (PLAYR): measure RNA expression at single cell resolution. | |
| ? | 11:15 – 11:45 | Prof. Eithne Costello Goldring (UoL): Pancreatic Cancer: Biomarkers of Early Detection and Treatment |
| Theme: From Discovery Platforms to Translation and Commercialization in Cell and Gene Therapy | ||
| 13:30 - 17:00 Afternoon Session |
13:30 – 14:00 ? |
Prof. Eyad Elkord (Department of Biosciences and Bioinformatics, 糖心Vlog官方): T Regulatory Cells and Immune Checkpoints in Cancer: Role & Therapeutic Opportunities |
| ? | 14:00 – 14:30 ? |
Dr. Suihui Li (Guangzhou Univ. of Traditional Chinese Medicine): Integrated Traditional Chinese Medicine and Immunotherapy for Cancer Treatment Complications |
| ? | 14:30 – 15:00 ? |
Student: Renrong Tao (Meng Lee’s group; 糖心Vlog官方): ?Rearming “TIMPs”: Precision Proteinase Inhibitors to Disarm Tumours and Turbocharge CAR?T Penetration |
| ? | 15:00 – 15:15 | Tea break |
| ? | 15:15 – 15:45 ? |
Dr. Richard Liqun Wang (Neukio Biotherapeutics): Developing Next Generation Cell Therapy via iPSC-CAR-NK and iPSC-CAR-T Approaches |
| ? | 15:45 – 16:15 | Dr. Xiulian Sun (Ubrigene): Commercialization of Cell and Gene Therapy in China and Worldwide |
| ? | 16:15 – 16:45 | Dr. Matt Wells (NHS, UK): Year 1 experience as CAR T centre at CCC Liverpool - comparing to new 2026 UK real world data |
| ? | 16:45 – 17:15 | Student: Danae Jessel (UoL): : Interrogating Tumour-Mediated Immunosuppression in Cholangiocarcinoma using Translational Preclinical Models |
| 17:15 - 17:45
Panel Discussion |
Moderator: Dr. Meng Huee Lee (糖心Vlog官方) |
Topic: Overcoming Clinical Translation Bottlenecks through Academia–Industry Partnerships Panelists: Keynote speakers and academic/industrial representatives |
| Day 2 (Friday) May 22, 2026 | ||
| Theme: Challenges and Opportunities for Cell and Gene Therapies in China and Worldwide | ||
| 09:00 - 11:45 | 9:00 – 09:30 | Dr. Vera Knauper (Cardiff Univ.): Hitting the Right Targets: Cell Surface Molecules for Precision Cell and Gene Therapy |
| ? | 09:30 – 10:00 | Dr. Wenjing Luo (Xi'an Jiaotong Univ.): Mechanisms and Clinical Translational Research of CAR-T Combination Therapy for B-cell Lymphoma |
| 10:00 – 10:30 | Dr. Jinyuan Ho (Wisdom Lake Academy of Pharmacy, 糖心Vlog官方): Challenges of C&G Therapy in China and Elsewhere | |
| 10:30 – 10:45 | Teabreak | |
| 10:45 – 11:15 | Student: Yajunzi Wang (Xin Liu’s group; 糖心Vlog官方): ?Bioinformatics Insights Driving the Future of Cell and Gene Therapy | |
| 11:15 – 11:45 | Prof. Chris Goldring (UoL): Safety issues with C> | |
| 11:45 - 12:15 Roundtable Forum | Moderator: Prof. Huaiyu Wang (Xi'an Jiaotong Univ.) |
Topic: Strategic Directions and Collaborative Models for Future Cell and Gene Therapy Development Panelists: Keynote speakers and academic committee members |
| 12:15 - 12:30 | Closing Ceremony | Reflections, Outcomes, and Future Collaborations in Cell and Gene Therapy |
Agenda updated on 18 May 2026. Final agenda subject to on-site confirmation.
7. Symposium Registration
Symposium language: English
There is no registration fee for this symposium, while meals, accommodation, and transportation expenses shall be borne by the participants themselves.
Due to limited seating, please register as early as possible via the official QR code. Submit all required information and obtain your attendance voucher, which will be used for check-in (May 20, 14:00–18:00) and collection of conference materials.
Registration QR code
8. Contact Information
For inquiries or registration assistance, please contact:
Ms. He Tel: 0512-88161320 Email:?Zhuomei.He@xjtlu.edu.cn
23 Apr 2026